Estimation of sojourn time in chronic disease screening without data on interval cases

Tony H H Chen, H. S. Kuo, M. F. Yen, M. S. Lai, L. Tabar, S. W. Duffy

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Estimation of the sojourn time on the preclinical detectable period in disease screening or transition rates for the natural history of chronic disease usually rely on interval cases (diagnosed between screens). However, to ascertain such cases might be difficult in developing countries due to incomplete registration systems and difficulties in follow-up. To overcome this problem, we propose three Markov models to estimate parameters without using interval cases. A three-state Markov model, a five-state Markov model related to regional lymph node spread, and a five-state Markov model pertaining to tumor size are applied to data on breast cancer screening in female relatives of breast cancer cases in Taiwan. Results based on a three- state Markov model give mean sojourn time (MST) 1.90 (95% CI: 1.18-4.86) years for this high-risk group. Validation of these models on the basis of data on breast cancer screening in the age groups 50-59 and 60-69 years from the Swedish Two-County Trial shows the estimates from a three-state Markov model that does not use interval cases are very close to those from previous Markov models taking interval cancers into account. For the five-state Markov model, a reparameterized procedure using auxiliary information on clinically detected cancers is performed to estimate relevant parameters. A good fit of internal and external validation demonstrates the feasibility of using these models to estimate parameters that have previously required interval cancers. This method can be applied to other screening data in which there are no data on interval cases.

Original languageEnglish
Pages (from-to)167-172
Number of pages6
JournalBiometrics
Volume56
Issue number1
Publication statusPublished - Mar 2000
Externally publishedYes

Fingerprint

Chronic Disease
Sojourn Time
chronic diseases
Markov Model
Screening
screening
Interval
Breast Neoplasms
Early Detection of Cancer
Neoplasms
Breast Cancer
breast neoplasms
Cancer
neoplasms
Taiwan
Estimate
Developing Countries
Age Groups
Lymph Nodes
Auxiliary Information

Keywords

  • Breast cancer
  • Chronic disease
  • Interval cases
  • Markov model
  • Screening
  • Sojourn time

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Public Health, Environmental and Occupational Health
  • Agricultural and Biological Sciences (miscellaneous)
  • Applied Mathematics
  • Statistics and Probability

Cite this

Chen, T. H. H., Kuo, H. S., Yen, M. F., Lai, M. S., Tabar, L., & Duffy, S. W. (2000). Estimation of sojourn time in chronic disease screening without data on interval cases. Biometrics, 56(1), 167-172.

Estimation of sojourn time in chronic disease screening without data on interval cases. / Chen, Tony H H; Kuo, H. S.; Yen, M. F.; Lai, M. S.; Tabar, L.; Duffy, S. W.

In: Biometrics, Vol. 56, No. 1, 03.2000, p. 167-172.

Research output: Contribution to journalArticle

Chen, THH, Kuo, HS, Yen, MF, Lai, MS, Tabar, L & Duffy, SW 2000, 'Estimation of sojourn time in chronic disease screening without data on interval cases', Biometrics, vol. 56, no. 1, pp. 167-172.
Chen THH, Kuo HS, Yen MF, Lai MS, Tabar L, Duffy SW. Estimation of sojourn time in chronic disease screening without data on interval cases. Biometrics. 2000 Mar;56(1):167-172.
Chen, Tony H H ; Kuo, H. S. ; Yen, M. F. ; Lai, M. S. ; Tabar, L. ; Duffy, S. W. / Estimation of sojourn time in chronic disease screening without data on interval cases. In: Biometrics. 2000 ; Vol. 56, No. 1. pp. 167-172.
@article{a3d3ac0348954cfabeca5e9a358fb046,
title = "Estimation of sojourn time in chronic disease screening without data on interval cases",
abstract = "Estimation of the sojourn time on the preclinical detectable period in disease screening or transition rates for the natural history of chronic disease usually rely on interval cases (diagnosed between screens). However, to ascertain such cases might be difficult in developing countries due to incomplete registration systems and difficulties in follow-up. To overcome this problem, we propose three Markov models to estimate parameters without using interval cases. A three-state Markov model, a five-state Markov model related to regional lymph node spread, and a five-state Markov model pertaining to tumor size are applied to data on breast cancer screening in female relatives of breast cancer cases in Taiwan. Results based on a three- state Markov model give mean sojourn time (MST) 1.90 (95{\%} CI: 1.18-4.86) years for this high-risk group. Validation of these models on the basis of data on breast cancer screening in the age groups 50-59 and 60-69 years from the Swedish Two-County Trial shows the estimates from a three-state Markov model that does not use interval cases are very close to those from previous Markov models taking interval cancers into account. For the five-state Markov model, a reparameterized procedure using auxiliary information on clinically detected cancers is performed to estimate relevant parameters. A good fit of internal and external validation demonstrates the feasibility of using these models to estimate parameters that have previously required interval cancers. This method can be applied to other screening data in which there are no data on interval cases.",
keywords = "Breast cancer, Chronic disease, Interval cases, Markov model, Screening, Sojourn time",
author = "Chen, {Tony H H} and Kuo, {H. S.} and Yen, {M. F.} and Lai, {M. S.} and L. Tabar and Duffy, {S. W.}",
year = "2000",
month = "3",
language = "English",
volume = "56",
pages = "167--172",
journal = "Biometrics",
issn = "0006-341X",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Estimation of sojourn time in chronic disease screening without data on interval cases

AU - Chen, Tony H H

AU - Kuo, H. S.

AU - Yen, M. F.

AU - Lai, M. S.

AU - Tabar, L.

AU - Duffy, S. W.

PY - 2000/3

Y1 - 2000/3

N2 - Estimation of the sojourn time on the preclinical detectable period in disease screening or transition rates for the natural history of chronic disease usually rely on interval cases (diagnosed between screens). However, to ascertain such cases might be difficult in developing countries due to incomplete registration systems and difficulties in follow-up. To overcome this problem, we propose three Markov models to estimate parameters without using interval cases. A three-state Markov model, a five-state Markov model related to regional lymph node spread, and a five-state Markov model pertaining to tumor size are applied to data on breast cancer screening in female relatives of breast cancer cases in Taiwan. Results based on a three- state Markov model give mean sojourn time (MST) 1.90 (95% CI: 1.18-4.86) years for this high-risk group. Validation of these models on the basis of data on breast cancer screening in the age groups 50-59 and 60-69 years from the Swedish Two-County Trial shows the estimates from a three-state Markov model that does not use interval cases are very close to those from previous Markov models taking interval cancers into account. For the five-state Markov model, a reparameterized procedure using auxiliary information on clinically detected cancers is performed to estimate relevant parameters. A good fit of internal and external validation demonstrates the feasibility of using these models to estimate parameters that have previously required interval cancers. This method can be applied to other screening data in which there are no data on interval cases.

AB - Estimation of the sojourn time on the preclinical detectable period in disease screening or transition rates for the natural history of chronic disease usually rely on interval cases (diagnosed between screens). However, to ascertain such cases might be difficult in developing countries due to incomplete registration systems and difficulties in follow-up. To overcome this problem, we propose three Markov models to estimate parameters without using interval cases. A three-state Markov model, a five-state Markov model related to regional lymph node spread, and a five-state Markov model pertaining to tumor size are applied to data on breast cancer screening in female relatives of breast cancer cases in Taiwan. Results based on a three- state Markov model give mean sojourn time (MST) 1.90 (95% CI: 1.18-4.86) years for this high-risk group. Validation of these models on the basis of data on breast cancer screening in the age groups 50-59 and 60-69 years from the Swedish Two-County Trial shows the estimates from a three-state Markov model that does not use interval cases are very close to those from previous Markov models taking interval cancers into account. For the five-state Markov model, a reparameterized procedure using auxiliary information on clinically detected cancers is performed to estimate relevant parameters. A good fit of internal and external validation demonstrates the feasibility of using these models to estimate parameters that have previously required interval cancers. This method can be applied to other screening data in which there are no data on interval cases.

KW - Breast cancer

KW - Chronic disease

KW - Interval cases

KW - Markov model

KW - Screening

KW - Sojourn time

UR - http://www.scopus.com/inward/record.url?scp=0034064237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034064237&partnerID=8YFLogxK

M3 - Article

C2 - 10783792

AN - SCOPUS:0034064237

VL - 56

SP - 167

EP - 172

JO - Biometrics

JF - Biometrics

SN - 0006-341X

IS - 1

ER -